Elevated COX-2 levels are associated with tumor progression in both human cancers and animal tumor models and have diverse etiologies including inflammation, tumor-driver mutations, radiation, and chemotherapy-induced immunogenic cell death (2, 20–23). Here, PTGER2 is linked to neoplasm.